Dr. José Larios Joins Karmanos Cancer Institute's Pioneering Hematology Team

Dr. José Larios Joins Karmanos Cancer Institute's Innovative Hematology Team

The Barbara Ann Karmanos Cancer Institute is thrilled to announce the appointment of Dr. José Larios, a transplant hematologist, to its esteemed Bone Marrow and Stem Cell Transplant and Hematology Oncology Multidisciplinary Teams. Dr. Larios brings a wealth of knowledge and expertise specializing in the treatment of blood cancers, particularly leukemia and lymphoma, including both Hodgkin and non-Hodgkin lymphomas.

Dr. Larios began his patient consultations at the Karmanos Cancer Center in Detroit in August 2024. He expressed his enthusiasm about joining this renowned institute, stating, "Karmanos Cancer Institute is an NCI-Designated Comprehensive Cancer Center known for its expertise in treating solid and hematologic tumors." His training during his fellowship involved working closely with outstanding transplant and hematology teams, emphasizing the significance of mentorship in his professional development.

His research and clinical interests primarily focus on the complex role of the bone marrow microenvironment in leukemia progression. Topics of interest include the signaling mechanisms within the bone marrow in acute leukemias, advancements in stem cell transplantation, and the evolution of cellular therapy. Dr. Larios's postdoctoral fellowship took place at the University of Michigan, where he conducted significant research on the molecular mechanics of endocrine resistance found in hormone receptor-positive breast cancer, employing pre-clinical models to represent newly identified mutations in the estrogen receptor gene.

Dr. Larios has also explored ways to counteract resistance to CDK4/6 inhibitors, which are crucial in oncology treatments today.

According to Dr. George Yoo, Chief Medical Officer at Karmanos, Dr. Larios's expertise is expected to greatly enhance leverages vital innovations in leukemia and lymphoma treatments through stem cell transplantation. He remarked, "Having physicians who push the standard of care forward is essential in the fight against cancer, helping to pave the way for future treatments that not only aim for a cure but also improve the quality of life post-treatment."

Dr. Larios's journey before joining Karmanos included completing an internal medicine residency at Ascension Providence Hospital in Southfield and earning his medical degree from Ross University School of Medicine in Dominica. He is board-certified by the American Board of Internal Medicine and is an active member of esteemed organizations, including the American Society of Hematology, the American Society of Clinical Oncology, and the American Medical Association. His contributions to the field are further highlighted by his role on the editorial board of the European Journal of Neurology, alongside a portfolio of co-authored peer-reviewed studies.

To seek an appointment with Dr. Larios, patients and their families can visit the Karmanos website or contact the center directly at 1-800-KARMANOS.

About Karmanos Cancer Institute

The Karmanos Cancer Institute stands out as a leader in transformative cancer care and research, driven by a vision of a world liberated from cancer. With its origins dating back over 75 years, it is part of McLaren Health Care and serves as Michigan’s largest provider of cancer care and research.
With a robust network of 16 sites, Karmanos delivers globally recognized care and access to clinical trials throughout Michigan and northern Ohio. Its comprehensive cancer center designation from the National Cancer Institute further solidifies its reputation among the best cancer facilities in the country. The institute collaborates with Wayne State University School of Medicine in influential educational endeavors aimed at defining new standards of cancer treatments and survivorship.

For further details about Karmanos or to explore their treatments, you can visit their website or follow them on various social media platforms.